Insider · CIK 0001356090 Also files as an issuer

Intrexon Corp

CIK 0001356090 Name as filed on the most recent filing

Filed as Intrexon Corp (29)

59 transaction lines · from 29 filings · filed 2011-01-14 to 2019-04-03 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2011-08-22 P, Open-market purchase Ziopharm Oncology IncZIOP 543,989, acquired Open Form 4 filing 0001140361-11-043206
2011-08-19 P, Open-market purchase Ziopharm Oncology IncZIOP 969,116, acquired Open Form 4 filing 0001140361-11-043206
2011-08-18 P, Open-market purchase Ziopharm Oncology IncZIOP 759,716, acquired Open Form 4 filing 0001140361-11-043206
2011-08-09 P, Open-market purchase Ziopharm Oncology IncZIOP 1,464,707, acquired Open Form 4 filing 0001140361-11-040682
2011-08-08 P, Open-market purchase Ziopharm Oncology IncZIOP 2,037,605, acquired Open Form 4 filing 0001140361-11-040682
2011-08-05 P, Open-market purchase Ziopharm Oncology IncZIOP 539,921, acquired Open Form 4 filing 0001140361-11-040682
2011-02-03 P, Open-market purchase Ziopharm Oncology IncZIOP 10,982,500, acquired Open Form 4 filing 0001140361-11-006511
2011-01-12 P, Open-market purchase Ziopharm Oncology IncZIOP Not reported Open Form 4 filing 0001140361-11-002888
2011-01-12 P, Open-market purchase Ziopharm Oncology IncZIOP 11,645,928, acquired Open Form 4 filing 0001140361-11-002888

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. INTREXON CORP, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001356090

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.